AL Amyloidosis - 146 Studies Found
| Completed |
: Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL) : Amyloidosis : 2011-01-03 : Drug: Bortezomib Bortezomib Other Name: autologous h |
| Completed |
: Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis : Amyloidosis : 2014-02-04 :
|
| Completed |
: Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation : Amyloidosis : 2012-03-15 |
| Active, not recruiting |
: Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. :
: 2016-09-19 :
|
| Terminated |
: Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis : Amyloidosis : 2015-09-09 : Drug: Idelalisib Idelalisib daily until unacceptable toxicity or disease progression. |
| Recruiting |
: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders :
|
| Completed |
: Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 2007-04-09 :
|
| Recruiting |
: Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma :
|
| Completed |
: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant :
: |
| Active, not recruiting |
: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer :
: |